Should single agents be standard therapy for urothelial tract tumors?

J Clin Oncol. 1989 Jun;7(6):694-7. doi: 10.1200/JCO.1989.7.6.694.

Author

H I Scher¹

Affiliation

¹ Memorial Sloan-Kettering Cancer Center, New York.

PMID: 2715800
DOI: 10.1200/JCO.1989.7.6.694

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Clinical Protocols
Epithelium / pathology
Humans
Urologic Neoplasms / drug therapy*